Results 191 to 200 of about 51,926 (267)

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review

open access: yesActa Psychiatrica Scandinavica, Volume 153, Issue 2, Page 95-107, February 2026.
ABSTRACT Introduction Posttraumatic stress disorder (PTSD) is a mental disorder resulting from exposure to traumatic events. Evidence suggests that ketamine may be efficacious in treating PTSD, however, ketamine's mechanisms in treating PTSD remain unclear. Herein, this review aims to evaluate the clinical outcomes of ketamine treatment in persons with
Liyang Yin   +15 more
wiley   +1 more source

Cocaine seeking and consumption are oppositely regulated by mesolimbic dopamine in male rats. [PDF]

open access: yesNat Commun
Burgeno LM   +10 more
europepmc   +1 more source

Trans‐Tissue Effects of Hippocampus‐ and Blood‐Derived DNA Methylation Risk Scores on Bipolar Disorder Diagnosis

open access: yesBipolar Disorders, Volume 28, Issue 1, February 2026.
ABSTRACT Objectives Bipolar disorder (BD) is a common psychiatric disorder with complex genetic and epigenetic underpinnings. This study aimed to investigate whether methylation risk scores (MRSs) derived from epigenome‐wide association studies (EWASs) for BD risk in living peripheral blood and postmortem hippocampal tissues are associated with BD ...
Kazutaka Ohi   +6 more
wiley   +1 more source

Drug-Induced Epigenetic Alterations: A Set of Forensic Toxicological Fingerprints?-A Systematic Review. [PDF]

open access: yesGenes (Basel)
Grassi S   +7 more
europepmc   +1 more source

Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 3, Page 505-519, February 2026.
Background and Purpose Riluzole, approved for amyotrophic lateral sclerosis (ALS), has a glutamate‐modulating profile favourable for mitigating opioid addiction. It reduces neuronal glutamate release and enhances glutamate reuptake, offering advantages over agents that only increase glutamate reuptake.
Ewa Galaj   +7 more
wiley   +1 more source

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Ecopipam is a first‐in‐class dopamine D1 receptor antagonist under investigation for the treatment of Tourette syndrome. This open‐label, fixed‐sequence, three‐cohort study evaluated whether ecopipam induces or inhibits cytochrome P450 (CYP) 1A2, CYP2B6, CYP2C19, CYP2D6, CYP3A4, organic anion‐transporting polypeptide (OATP) 1B1, and p ...
Virginia D. Schmith   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy